Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Yangxue Qingnao Pill in the Treatment of Mild Vascular Cognitive Impairment Without Dementia (VCIND)

NCT04958512 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04958512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04958512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Yangxue Qingnao Pill in the Treatment of Mild Vascular Cognitive Impairment Without Dementia (VCIND)
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 30, 2017
Completion date
March 31, 2018
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular diseases